Literature DB >> 15449198

Non-enhancing de novo glioblastoma: report of two cases.

Aaron A Cohen-Gadol1, Michael L DiLuna, Sergei I Bannykh, Joseph M Piepmeier, Dennis D Spencer.   

Abstract

Malignant gliomas arise from two distinct pathways, as de novo lesions or from secondary transformation from low-grade lesions. Herein, we describe the cases of two patients to illustrate the proposition that de novo malignant gliomas can originate as non-enhancing tumors and rapidly progress to a pattern of ring enhancement characteristic of a glioblastoma. Both patients presented with new-onset seizures (simple partial and generalized). Their neurological examinations were unremarkable. Initial MRI evaluations revealed a right precentral gyrus and right medial temporal lobe lesions in each case, respectively. These lesions demonstrated increased T2 signal changes without contrast enhancement. The biopsy of the right frontal lesion in the first patient was consistent with an anaplastic astrocytoma; the second patient was followed expectantly. Repeat MRI for both patients within 17 weeks disclosed ring-enhancing lesions, consistent with an unusually rapid evolution to glioblastoma multiforme (GBM). Subsequent resection of the right medial temporal lesion in the second patient revealed a GBM. Neither tumor displayed abnormal overexpression of P53 by immunohistochemistry. Early MRI of de novo glioblastomas may demonstrate a non-enhancing tumor suggestive of a low-grade lesion. These tumors can rapidly evolve into ring-enhancing lesions more consistent with the traditional imaging findings. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15449198     DOI: 10.1007/s10143-004-0346-5

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  29 in total

1.  Prognostic significance of preoperative MRI scans in glioblastoma multiforme.

Authors:  M A Hammoud; R Sawaya; W Shi; P F Thall; N E Leeds
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Suspected low-grade glioma: is deferring treatment safe?

Authors:  L D Recht; R Lew; T W Smith
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

3.  Preoperative history and postoperative survival of supratentorial low-grade astrocytomas.

Authors:  D Afra; E Osztie; L Sipos; D Vitanovics
Journal:  Br J Neurosurg       Date:  1999-06       Impact factor: 1.596

4.  MRI of high-grade astrocytic tumors: early appearance and evolution.

Authors:  K Okamoto; J Ito; N Takahashi; K Ishikawa; T Furusawa; S Tokiguchi; K Sakai
Journal:  Neuroradiology       Date:  2002-02-19       Impact factor: 2.804

5.  Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas.

Authors:  M C Chamberlain; J A Murovic; V A Levin
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

6.  Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme.

Authors:  M Fujimoto; D W Fults; G A Thomas; Y Nakamura; M P Heilbrun; R White; J L Story; S L Naylor; K S Kagan-Hallet; P J Sheridan
Journal:  Genomics       Date:  1989-02       Impact factor: 5.736

7.  Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.

Authors:  A von Deimling; D N Louis; K von Ammon; I Petersen; T Hoell; R Y Chung; R L Martuza; D A Schoenfeld; M G Yaşargil; O D Wiestler
Journal:  J Neurosurg       Date:  1992-08       Impact factor: 5.115

8.  Serial nonenhancing magnetic resonance imaging scans of high grade glioblastoma multiforme.

Authors:  J Moore-Stovall; R Venkatesh
Journal:  J Natl Med Assoc       Date:  1993-02       Impact factor: 1.798

9.  Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas.

Authors:  S H Torp; E Helseth; A Dalen; G Unsgaard
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

10.  Contrast-enhanced MR imaging of malignant brain tumors.

Authors:  M Graif; G M Bydder; R E Steiner; P Niendorf; D G Thomas; I R Young
Journal:  AJNR Am J Neuroradiol       Date:  1985 Nov-Dec       Impact factor: 3.825

View more
  10 in total

1.  MRI findings and pathological features in early-stage glioblastoma.

Authors:  Makoto Ideguchi; Koji Kajiwara; Hisaharu Goto; Kazutaka Sugimoto; Sadahiro Nomura; Eiji Ikeda; Michiyasu Suzuki
Journal:  J Neurooncol       Date:  2015-05-05       Impact factor: 4.130

2.  Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.

Authors:  C H Toh; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-17       Impact factor: 3.825

Review 3.  Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature.

Authors:  Mahmoud Reza Khalatbari; Mehrdokht Hamidi; Yashar Moharamzad
Journal:  Childs Nerv Syst       Date:  2011-06-08       Impact factor: 1.475

Review 4.  Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.

Authors:  Jill M Abrigo; Daniel M Fountain; James M Provenzale; Eric K Law; Joey Sw Kwong; Michael G Hart; Wilson Wai San Tam
Journal:  Cochrane Database Syst Rev       Date:  2018-01-22

5.  Early stage glioblastoma: retrospective multicentric analysis of clinical and radiological features.

Authors:  Isabella Ceravolo; Giovanni Barchetti; Francesco Biraschi; Carmela Gerace; Enrico Pampana; Alberto Pingi; Alessandro Stasolla
Journal:  Radiol Med       Date:  2021-08-02       Impact factor: 3.469

6.  Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis.

Authors:  Whitney B Pope; Jenny H Chen; Jun Dong; Marc R J Carlson; Alla Perlina; Timothy F Cloughesy; Linda M Liau; Paul S Mischel; Phioanh Nghiemphu; Albert Lai; Stanley F Nelson
Journal:  Radiology       Date:  2008-10       Impact factor: 11.105

7.  Diagnostic Performance of Arterial Spin Labeling for Grading Nonenhancing Astrocytic Tumors.

Authors:  Delgerdalai Khashbat; Masafumi Harada; Takashi Abe; Mungunbagana Ganbold; Seiji Iwamoto; Naoto Uyama; Saho Irahara; Youichi Otomi; Teruyoshi Kageji; Shinji Nagahiro
Journal:  Magn Reson Med Sci       Date:  2017-12-12       Impact factor: 2.471

8.  Genetic Alteration May Proceed with a Histological Change in Glioblastoma: A Report from Initially Diagnosed as Nontumor Lesion Cases.

Authors:  Hayato Takeuchi; Yoshinobu Takahashi; Seisuke Tanigawa; Takanari Okamoto; Yoshinori Kodama; Yukiko Shishido-Hara; Ema Yoshioka; Tomoko Shofuda; Yonehiro Kanemura; Eiichi Konishi; Naoya Hashimoto
Journal:  NMC Case Rep J       Date:  2022-07-08

9.  Additional Diagnostic Value of Unenhanced Computed Tomography plus Diffusion-Weighted Imaging Combined with Routine Magnetic Resonance Imaging Findings of Early-Stage Gliblastoma.

Authors:  Hexiang Wang; Zhenyou Liu; Yong Zhang; Feng Hou; Weiwei Fu; Jizheng Lin; Yingchao Liu; Xuejun Liu
Journal:  Biomed Res Int       Date:  2020-02-18       Impact factor: 3.411

10.  Differentiation of Low-Grade Astrocytoma From Anaplastic Astrocytoma Using Radiomics-Based Machine Learning Techniques.

Authors:  Boran Chen; Chaoyue Chen; Jian Wang; Yuen Teng; Xuelei Ma; Jianguo Xu
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.